Primary Site >> Liver Cancer
Gene >> IRAK1
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway. PMID: 20937539 Ref: Alterations in the expression of genes related to NF-kappaB signaling in liver and kidney of CuZnSOD-deficient mice. PMID: 21472504 |
Ref: Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice. PMID: 25049387 |
Ref: STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma. PMID: 26457732 |
Ref: Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas. PMID: 28356759 |
Ref: Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma. PMID: 29025272 Ref: IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma. PMID: 29483095 Ref: Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis. PMID: 29785143 Ref: Functional Polymorphisms in IRAKs Are Related to Hepatocellular Carcinoma Risk in Chinese Population. PMID: 30112356 Ref: Cytokine-mediated modulation of the hepatic miRNome: miR-146b-5p is an IL-6-inducible miRNA with multiple targets. PMID: 30145833 |